FILE PHOTO: A sign marks the headquarters of Moderna in

FILE PHOTO: A sign marks the headquarters of the coronavirus disease (COVID-19) vaccine maker Moderna in Cambridge, Massachusetts, U.S., April 28, 2022. REUTERS/Brian Snyder/File Photo

Post navigation

Previous: Moderna secures $750 million from Blackstone Life Sciences to develop flu shots

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Search

You may have missed

2025-08-27T150238Z_1_LYNXMPEL7Q0OW_RTROPTP_4_SCIENCE-PELVIS-2

Uncategorized

Two evolutionary changes underpinning human bipedalism are discovered

Bull Bear Daily August 27, 2025

Newsletters

Leaders, journalist groups react to Israeli Gaza strike that killed five journalists

Bull Bear Daily August 25, 2025

2025-08-25T140007Z_1_LYNXMPEL7O0JL_RTROPTP_4_DEUTSCHETELEKOM-RESULTS

Uncategorized

Currency spikes and Trump tariffs take bite out of European results

Bull Bear Daily August 25, 2025

2025-08-25T175432Z_1_LYNXMPEL7O0RY_RTROPTP_4_ISRAEL-PALESTINIANS-GAZA

Uncategorized

Leaders, journalist groups react to Israeli Gaza strike that killed five journalists

Bull Bear Daily August 25, 2025

Home
Privacy Policy
Terms of Service
Disclaimer
Contact Us